Very sad and disappointing to hear this news about birinapant. Unfortunately, also the new company that has bought the rights from Tetralogic is not going to have any hbv clinical tests with birinapant, at least for now. On their website they write about their plans to start two clinical trials with birinapant against cancer.
Tetralogic will also terminate all remaining employees by the end of this month, Delists from Nasdaq since it's stock price has fallen to 9 cents.